Literature DB >> 9657659

Sarcoidosis induced by interferon therapy for chronic myelogenous leukaemia.

M Kikawada1, Y Ichinose, A Kunisawa, N Yanagisawa, K Minemura, I Kasuga, M Yonemaru, K Kawanishi, M Takasaki, K Toyama.   

Abstract

A 31-year-old male was diagnosed as having chronic myelogenous leukaemia and has been treated with hydroxyurea and interferon-alpha since February 1995. After 16 months, he complained of low-grade fever and a cough. Bilateral hilar lymph node enlargement was detected on the chest X-ray film and multiple subcutaneous erythematous nodules appeared. A skin biopsy revealed subcutaneous sarcoid granuloma. Two months after the cessation of interferon therapy, the subcutaneous nodules and the hilar lymph node enlargement resolved. It is possible that continuous interferon administration can promote granuloma formation in sarcoidosis by activating T cells and macrophages.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657659     DOI: 10.1046/j.1440-1843.1998.d01-1.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  6 in total

1.  Sarcoidosis following Chemotherapy of Essential Thrombocythemia with Hydroxyurea.

Authors:  Mps Sawhney; D K Mishra
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 2.  Granulomatous reactions cause symptoms or clinically imitate treatment resistance in small lymphocytic lymphoma/chronic lymphocytic leukaemia more frequently than in other non-Hodgkin lymphomas.

Authors:  A Brunner; J Kantner; A Tzankov
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

Review 3.  Dendritic cells in the pathogenesis of sarcoidosis.

Authors:  Lisa C Zaba; Gideon P Smith; Miguel Sanchez; Stephen D Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-16       Impact factor: 6.914

Review 4.  Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.

Authors:  Bobbak Vahid; Paul E Marik
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

5.  Amyloïdosis, sarcoidosis and systemic lupus erythematosus.

Authors:  Amel Rezgui; Imene Ben Hassine; Monia Karmani; Fatma Ben Fredj; Chadia Laouani
Journal:  Pan Afr Med J       Date:  2016-05-06

6.  Bone marrow sarcoidosis associated with long-term interferon-β treatment for multiple sclerosis.

Authors:  Angela Teh; Patrick Russell; Jordan Li; Udul Hewage
Journal:  Clin Case Rep       Date:  2016-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.